AccuStem Sciences, Inc. is a clinical stage diagnostics company, which engages in medical practice activities. It also focuses on commercialization of a proprietary genomic test, StemPrintER, for patients with early-stage breast cancer. The company was founded by Gabriele Marco Antonio Cerrone on June 5, 2020 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
4
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Accustem Sciences Inc market cap is $1.9M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Accustem Sciences Inc 52 week high is $0.9035 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Accustem Sciences Inc 52 week low is $0.117 as of November 22, 2026.
Accustem Sciences Inc stock price today is $0.118.
Accustem Sciences Inc stock price yesterday was $0.118.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Accustem Sciences Inc's P/E ratio is -1.15.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Accustem Sciences Inc P/B ratio is -0.4606.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Accustem Sciences Inc 50-day moving average is $0.1339.